Abacus Bioscience

Seattle, United States

Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.

$4.4M raised

Feb 2023

Seed

Biotechnology Health Care Medical Therapeutics

Top Investors

Seagen

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Abacus Bioscience

How much funding has Abacus Bioscience raised?

Abacus Bioscience has raised $4.4M in total funding. The most recent round was Seed. The last funding was announced in February 2023.

Who are Abacus Bioscience's investors?

Abacus Bioscience's investors include Seagen.

Where is Abacus Bioscience headquartered?

Abacus Bioscience is headquartered in Seattle, United States.

What does Abacus Bioscience do?

Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.

What stage is Abacus Bioscience at?

Abacus Bioscience is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 1, 2023.

MLA

"Abacus Bioscience — Funding & Investors." VCBacked, February 1, 2023, https://www.vcbacked.co/company/abacus-bioscience. Accessed July 3, 2026.

APA

VCBacked. (2023). Abacus Bioscience — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/abacus-bioscience

Wikipedia (cite web)

{{cite web |title=Abacus Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/abacus-bioscience |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 1, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K